Sigyn Therapeutics Inc

(OTC:SIGY)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Sigyn Therapeutics Inc is a development-stage therapeutic technology company. Its focus is directed toward a unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Sigyn Therapy is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a cause of SARS-CoV-2 (COVID-19) deaths.

Contact Information

Website: www.sigyntherapeutics.com
Email: info@reignsapphires.com
Main Phone: +1 619 368-2000
Address: 8880 Rio San Diego Drive
Address 2: Suite 800
State: CA
City / Town: San Diego
Country: US
Postal Code: 92108

Issuer Information

Exchange: OTO
Employees: 2
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A